Peptide and protein imaging mass spectrometry in cancer research

Journal of Proteomics

Volumn 73, Issue 10, 2010, Pages 1921-1944

  McDonnell, Liam A ^a   Corthals, Garry L ^b   Willems, Stefan M ^a   van Remoortere, Alexandra ^a   van Zeijl, René J M ^a   Deelder, André M ^a  

^a LEIDEN UNIVERSITY MEDICAL CENTER   (Netherlands)

^b TURKU CENTRE FOR BIOTECHNOLOGY   (Finland)

Author keywords

Biomarker; Cancer; Histopathology; Imaging mass spectrometry; MALDI; MSI

Indexed keywords

CALCIUM BINDING PROTEIN; EPIDERMAL GROWTH FACTOR RECEPTOR 2; ESTROGEN RECEPTOR; GLUCOSE REGULATED PROTEIN 78; MITOGEN ACTIVATED PROTEIN KINASE KINASE KINASE 2; PEROXIREDOXIN 1; PLASTIN 2; PROGESTERONE RECEPTOR; THYMOSIN BETA4; TUMOR MARKER; UBIQUITIN; UNCLASSIFIED DRUG;

BRAIN TUMOR; BREAST CANCER; CANCER RESEARCH; CELL SURVIVAL; CELL TYPE; GASTROINTESTINAL TUMOR; HISTOPATHOLOGY; HUMAN; IMAGING SYSTEM; LUNG CANCER; MATRIX ASSISTED LASER DESORPTION IONIZATION TIME OF FLIGHT MASS SPECTROMETRY; NONHUMAN; OVARY CANCER; PRIORITY JOURNAL; PROGNOSIS; PROSTATE CANCER; PROTEIN ANALYSIS; PROTEIN EXPRESSION; PROTEIN LOCALIZATION; REVIEW; SENSITIVITY AND SPECIFICITY; TUMOR BIOPSY;

BIOPSY; BRAIN CHEMISTRY; BRAIN NEOPLASMS; BREAST NEOPLASMS; FEMALE; GASTROINTESTINAL NEOPLASMS; HUMANS; LUNG NEOPLASMS; MALE; NEOPLASM PROTEINS; OVARIAN NEOPLASMS; PANCREATIC NEOPLASMS; PROSTATIC NEOPLASMS; PROTEOMICS; SPECIMEN HANDLING; SPECTROMETRY, MASS, MATRIX-ASSISTED LASER DESORPTION-IONIZATION; TUMOR MARKERS, BIOLOGICAL;

EID: 77956407293     PISSN: 18743919     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.jprot.2010.05.007     Document Type: Review

References (106)

1. Ferlay J., Autier P., Boniol M., Heanue M., Colombet M., Boyle P. Estimates of the cancer incidence and mortality in Europe in 2006. Ann Oncol 2007, 18:581-592.
2. Anderson N.L., Anderson N.G. The human plasma proteome. History, character and diagnostic prospects. Mol Cell Proteomics 2002, 1:845-867.
3. Wright M.E., Han D.K., Aebersold R. Mass spectrometry-based expression profiling of clinical prostate cancer. Mol Cell Proteomics 2005, 4:545-4.
4. Gerszten R.E., Accurso F., Bernard G.R., Caprioli R.M., Klee E.W., Klee G.G., et al. Challenges in translating plasma proteomics from bench to bedside: update from the NHLBI Clinical Proteomics Programs. Am J Physiol Lung Cell Mol Physiol 2008, 295:L16-L22.
5. Hortin GL, Sviridov D. The dynamic range problem in the analysis of the plasma proteome. J Proteomics 2010;73:629-36.
6. Pieragostino D., Petrucci F., Boccio P.D., Mantini D., Lugaresi A., Tiberio S., et al. Pre-analytical factors in clinical proteomics investigations: impact of ex vivo protein modifications for multiple sclerosis biomarker discovery. J Proteomics 2009, 73:579-592.
7. Sitek B., Sipos B., Alkatout I., Poschmann G., Stephan C., Schulenborg T., et al. Analysis of the pancreatic tumor progression by a quantitative proteomic approach and immunohistochemical validation. J Proteom Res 2009, 8:1647-1656.
8. Han M.H., Hwang S.-I., Roy D.B., Lundgren D.H., Price J.V., Ousman S.S., et al. Proteomic analysis of active multiple sclerosis lesions reveals therapeutic targets. Nature 2007, 451:1076-1081.
9. Reyzer M.L., Caldwell R.L., Dugger T.C., Forbes J.T., Ritter C.A., Guix M., et al. Early changes in protein expression detected by mass spectrometry predict tumor response to molecular therapeutics. Cancer Res 2004, 64:9093-9100.
10. Schwartz S.A., Weil R.J., Johnson M.D., Toms S.A., Caprioli R.M. Protein profiling in brain tumors using mass spectrometry: feasibility of a new technique for the analysis of protein expression. Clin Cancer Res 2004, 10:981-987.
11. Schwartz S.A., Weil R.J., Thompson R.C., Shyr Y., Moore J.H., Toms S.A., et al. Proteomic-based prognosis of brain tumor patients using direct-tissue matrix-assisted laser desorption ionization mass spectrometry. Cancer Res 2005, 65:7674-7681.
12. Cornett D.S., Mobley J.A., Dias E.C., Andersson M., Arteaga C.L., Sanders M.E., et al. A novel histology-directed strategy for MALDI-MS tissue profiling that improves throughput and cellular specificity in human breast cancer. Mol Cell Proteomics 2006, 5:1975-1983.
13. Seeley E.H., Caprioli R.M. Imaging mass spectrometry: towards clinical diagnostics. Proteomics Clin Appl 2008, 2:1435-1443.
14. Cornett D.S., Reyzer M.L., Chaurand P., Caprioli R.M. MALDI imaging mass spectrometry: molecular snapshots of biochemical systems. Nat Meth 2007, 4:828-833.
15. MacAleese L., Stauber J., Heeren R.M.A. Perspectives for imaging mass spectrometry in the proteomics landscape. Proteomics 2009, 9:819-834.
16. McDonnell L.A., Heeren R.M.A. Imaging mass spectrometry. Mass Spectrom Rev 2007, 26:606-643.
17. Groseclose M.R., Massion P.P., Chaurand P., Caprioli R.M. High-throughput proteomic analysis of formalin-fixed paraffin-embedded tissue microarrays using MALDI imaging mass spectrometry. Proteomics 2008, 8:3715-3724.
18. Stoeckli M., Chaurand P., Hallahan D.E., Caprioli R.M. Imaging mass spectrometry: a new technology for the analysis of protein expression in mammalian tissues. Nat Med 2001, 7:493-496.
19. Leinweber B.D., Tsaprailis G., Monks T.J., Lau S.S. Improved MALDI-TOF imaging yields increased protein signals at high molecular mass. J Am Soc Mass Spectrom 2009, 20:89-95.
20. Lemaire R., Tabet J.C., Ducoroy P., Hendra J.B., Salzet M., Fournier I. Solid ionic matrixes for direct tissue analysis and MALDI imaging. Anal Chem 2006, 78:809-819.
21. Lemaire R., Wisztorski M., Desmons A., Tabet J.C., Day R., Salzet M., et al. MALDI-MS direct tissue analysis of proteins: improving signal sensitivity using organic treatments. Anal Chem 2006, 78:7145-7153.
22. Schwartz S.A., Reyzer M.L., Caprioli R.M. Direct tissue analysis using matrix-assisted laser desorption/ionization mass spectrometry: practical aspects of sample preparation. J Mass Spectrom 2003, 38:699-708.
23. Seeley E.H., Oppenheimer S.R., Mi D., Chaurand P., Caprioli R.M. Enhancement of protein sensitivity for MALDI imaging mass spectrometry after chemical treatment of tissue sections. J Am Soc Mass Spectrom 2008, 19:1069-1077.
24. Chaurand P., Schwartz S.A., Billheimer D., Xu B.J., Crecelius A., Caprioli R.M. Integrating histology and imaging mass spectrometry. Anal Chem 2004, 76:1145-1155.
25. Schwamborn K., Krieg R.C., Reska M., Jakse G., Knuechel R., Wellmann A. Identifying prostate carcinoma by MALDI-imaging. Int J Mol Med 2007, 20:155-159.
26. Sinha T.K., Khatib-Shahidi S., Yankeelov T.E., Mapara K., Ehtesham M., Cornett D.S., et al. Integrating spatially resolved three dimensional MALDI IMS with in vivo magnetic resonance imaging. Nat Meth 2008, 5:57-59.
27. Deininger S.O., Ebert M.P., Futterer A., Gerhard M., Rocken C. MALDI imaging combined with hierarchical clustering as a new tool for the interpretation of complex human cancers. J Proteome Res 2008, 7:5230-5236.
28. McCombie G., Staab D., Stoeckli M., Knochenmuss R. Spatial and spectral correlations in MALDI mass spectrometry images by clustering and multivariate analysis. Anal Chem 2005, 77:6118-6124.
29. McDonnell L.A., van Remoortere A., van Zeijl R.J.M., Deelder A.M. Mass spectrometry image correlation: quantifying co-localization. J Proteom Res 2008, 7:3619-3627.
30. Pevsner P.H., Melamed J., Remsen T., Kogos A., Francois F., Kessler P., et al. Mass spectrometry MALDI imaging of colon cancer biomarkers: a new diagnostic paradigm. Biomarkers Med 2009, 3:55-69.
31. Zabel C., Andrew A., Mao L., Hartl D. Protein expression overlap: more important than which proteins change in expression?. Expert Rev Proteomic 2008, 5:187-205.
32. Seeley E.H., Caprioli R.M. Molecular imaging of proteins in tissues by mass spectrometry. Proc Natl Acad Sci U S A 2008, 105:18126-18131.
33. Cornett D.S., Frappier S.L., Caprioli R.M. MALDI-FTICR imaging mass spectrometry of drugs and metabolites in tissue. Anal Chem 2008, 80:5648-5653.
34. Reyzer M.L., Hsieh Y., Ng K., Korfmacher W.A., Caprioli R.M. Direct analysis of drug candidates in tissue by matrix-assisted laser desorption/ionization mass spectrometry. J Mass Spectrom 2003, 38:1081-1092.
35. Dreisewerd K. The desorption process in MALDI. Chem Rev 2003, 103:395-425.
36. Karas M., Krüger R. Ion formation in MALDI: the cluster ionization mechanism. Chem Rev 2003, 103:427-439.
37. Aebersold R., Mann M. Mass spectrometry-based proteomics. Nat Insights 2003, 422:198-207.
38. Deininger S.-O., Ebert M.P., Fütterer A., Gerhard M., Röcken C. MALDI imaging combined with hierarchical clustering as a new tool for the interpretation of complex human cancers. J Proteome Res 2008, 7:5230-5236.
39. Skold K., Svensson M., Norrman M., Sjogren B., Svenningsson P., Andren P.E. The significance of biochemical and molecular sample integrity in brain proteomics and peptidomics: stathmin 2-20 and peptides as sample quality indicators. Proteomics 2007, 7:4445-4456.
40. Espina V., Edmiston K.H., Heiby M., Pierobon M., Sciro M., Merritt B., et al. A portrait of tissue phosphoprotein stability in the clinical tissue procurement process. Mol Cell Proteomics 2008, 7:1998-2018.
41. Goodwin R.J.A., Dungworth J.C., Cobb S.R., Pitt A.R. Time-dependent evolution of tissue markers by MALDI-MS imaging. Proteomics 2008, 8:3801-3808.
42. Svensson M., Boren M., Skold K., Falth M., Sjogren B., Andersson M., et al. Heat stabilization of the tissue proteome: a new technology for improved proteomics. J Proteom Res 2009, 8:974-981.
43. Chaurand P., Latham J.C., Lane K.B., Mobley J.A., Polosukhin V.V., Wirth P.S., et al. Imaging mass spectrometry of intact proteins from alcohol-preserved tissue specimens: bypassing formalin fixation. J Proteome Res 2008, 7:3543-3555.
44. Mangé A., Chaurand P., Perrochia H., Roger P., Caprioli R.M., Solassol J. Liquid chromatography-tandem and MALDI imaging mass spectrometry analyses of RCL2/CS100-fixed, paraffin-embedded tissues: proteomics evaluation of an alternate fixative for biomarker discovery. J Proteom Res 2009, 8:5619-5628.
45. Djidja M.-C., Claude E., Snel M.F., Scriven P., Francese S., Carolan V., et al. MALDI-ion mobility separation-mass spectrometry imaging of glucose-regulated protein 78kDa (Grp78) in human formalin-fixed, paraffin-embedded pancreatic adenocarcinoma tissue sections. J Proteome Res 2009, 8:4876-4884.
46. Djidja M.-C., Claude E., Snel M.F., Francese S., Scriven P., Carolan V., et al. Novel molecular tumour classification using MALDI-mass spectrometry imaging of tissue micro-array. Anal Bioanal Chem 2010, 397:587-601.
47. Grey A.C., Chaurand P., Caprioli R.M., Schey K.L. MALDI imaging mass spectrometry of integral membrane proteins from ocular lens and retinal tissue. J Proteome Res 2009, 8:3278-3283.
48. Djidja M.C., Francese S., Loadman P.M., Sutton C.W., Scriven P., Claude E., et al. Detergent addition to tryptic digests and ion mobility separation prior to MS/MS improves peptide yield and protein identification for in situ proteomic investigation of frozen and formalin-fixed paraffin-embedded adenocarcinoma tissue sections. Proteomics 2009, 9:2750-2763.
49. Franck J, Longuespee R, Wisztorski M, van Remoortere A, van Zeijl R, André Deelder, et al. MALDI mass spectrometry imaging of high mass proteins. Med Sci Monit in press.
50. Altelaar A.F., Luxembourg S.L., McDonnell L.A., Piersma S.R., Heeren R.M. Imaging mass spectrometry at cellular length scales. Nat Protoc 2007, 2:1185-1196.
51. Chaurand P., Schwartz S.A., Caprioli R.M. Profiling and imaging proteins in tissue sections by MS. Anal Chem 2004, 76:86A-93A.
52. Franck J., Arafah K., Barnes A., Wisztorski M., Salzet M., Fournier I. Improving tissue preparation for matrix-assisted laser desorption ionization mass spectrometry imaging. Part 1: Using microspotting. Anal Chem 2009, 81:8193-8202.
53. Kaletas B.K., van der Wiel I.M., Stauber J., Dekker L.J., Güzel C., Kros J.M., et al. Sample preparation issues for tissue imaging by imaging MS. Proteomics 2009, 9:2622-2633.
54. Kruse R., Sweedler J.V. Spatial profiling invertebrate ganglia using MALDI MS. J Am Soc Mass Spectrom 2003, 14:752-759.
55. Altelaar A.F.M., Taban I.M., McDonnell L.A., Verhaert P.D.E.M., de Lange R.P.J., Adan R.A.H., et al. High-resolution MALDI imaging mass spectrometry allows localization of peptide distributions at cellular length scales in pituitary tissue sections. Int J Mass Spectrom 2007, 260:203-211.
56. Deininger S.-O., Höhndorf J., Becker M., Holle A., Schürenberg M., Fütterer A., et al. HUPO VIII Toronto 2009.
57. Hankin J.A., Barkley R.M., Murphy R.C. Sublimation as a method of matrix application for mass spectrometric imaging. J Am Soc Mass Spectrom 2007, 18:1646-1652.
58. Puolitaival S.M., Burnum K.E., Cornett D.S., Caprioli R.M. Solvent-free matrix dry-coating for MALDI imaging of phospholipids. J Am Soc Mass Spectrom 2008, 19:882-886.
59. Karas M., Bahr U., Fournier I., Glückmann M., Pfenninger A. The initial-ion velocity as a marker for different desorption-ionization mechanisms in MALDI. Int J Mass Spectrom 2003, 226:239-248.
60. Hardouin J. Protein sequence information by matrix-assisted laser desorption/ionization in-source decay mass spectrometry. Mass Spectrom Rev 2007, 26:672-682.
61. Lemaire R., Desmons A., Tabet J.C., Day R., Salzet M., Fournier I. Direct analysis and MALDI imaging of formalin-fixed, paraffin-embedded tissue sections. J Proteome Res 2007, 6:1295-1305.
62. Ronci M., Bonanno E., Colantoni A., Pieroni L., Di Ilio C., Spagnoli L.G., et al. Protein unlocking procedures of formalin-fixed paraffin-embedded tissues: application to MALDI-TOF imaging MS investigations. Proteomics 2008, 8:3702-3714.
63. Cazares L.H., Troyer D., Mendrinos S., Lance R.A., Nyalwidhe J.O., Beydoun H.A., et al. Imaging mass spectrometry of a specific fragment of mitogen-activated protein kinase/extracellular signal-regulated kinase kinase kinase 2 discriminates cancer from uninvolved prostate tissue. Clin Cancer Res 2009, 15:5541-5551.
64. Scherl A., Tsai Y.S., Shaffer S.A., Goodlett D.R. Increasing information from shotgun proteomic data by accounting for misassigned precursor ion masses. Proteomics 2008, 8:2791-2797.
65. Franck J., El Ayed M., Wisztorski M., Salzet M., Fournier I. On-tissue N-terminal peptide derivatizations for enhancing protein identification in MALDI mass spectrometric imaging strategies. Anal Chem 2009, 81:8305-8317.
66. McLean J.A., Ridenour W.B., Caprioli R.M. Profiling and imaging of tissues by imaging ion mobility-mass spectrometry. J Mass Spectrom 2007, 42:1099-1105.
67. Shimma S., Sugiura Y., Hayasaka T., Zaima N., Matsumoto M., Setou M. Mass imaging and identification of biomolecules with MALDI-QIT-TOF-based system. Anal Chem 2008, 80:878-885.
68. Landgraf R.R., Conaway M.C.P., Garrett T.J., Stacpoole P.W., Yost R.A. Imaging of lipids in spinal cord using intermediate pressure matrix-assisted laser desorption-linear ion trap/Orbitrap MS. Anal Chem 2009, 81:8488-8495.
69. Taban I.M., Altelaar A.F.M., Fuchser J., van der Burgt Y.E.M., McDonnell L.A., Baykut G., et al. Imaging of peptides in the rat brain using MALDI-FTICR mass spectrometry. J Am Soc Mass Spectrom 2007, 18:145-151.
70. Verhaert P.D., Conaway M.C.P., Pekar T.M., Miller K. Neuropeptide imaging on an LTQ with vMALDI source: the complete 'all-in-one' peptidome analysis. Int J Mass Spectrom 2007, 260:177-184.
71. Hopfgartner G., Varesio E., Stoeckli M. Matrix-assisted laser desorption/ionization mass spectrometric imaging of complete rat sections using a triple quadrupole linear ion trap. Rapid Commun Mass Spectrom 2009, 23:733-736.
72. Van de Plas R., Ojeda F., Dewil M., Van Den Bosch L., De Moor B., Waelkens E. Prospective exploration of biochemical tissue composition via imaging mass spectrometry guided by principal component analysis. Pac Symp Biocomput 2007, 458-469.
73. van Remoortere A, Willems SM, van Zeijl RJM, Hogendoorn PCW, Deelder AM, McDonnell LA. Imaging mass spectrometry: introduction, application to tumors of the pancreas and prospects. submitted to Histopathology 2010.
74. Hanselmann M., Kirchner M., Renard B.Y., Amstalden E.R., Glunde K., Heeren R.M.A., et al. Concise representation of mass spectrometry images by probabilistic latent semantic analysis. Anal Chem 2008, 80:9649-9658.
75. Hanselmann M., Kothe U., Kirchner M., Renard B.Y., Amstalden E.R., Glunde K., et al. Toward digital staining using imaging mass spectrometry and random forests. J Proteom Res 2009, 8:3558-3567.
76. Chaurand P., Schwartz S.A., Caprioli R.M. Assessing protein patterns in disease using imaging mass spectrometry. J Proteom Res 2004, 3:245-252.
77. Chaurand P., Sanders M.E., Jensen R.A., Caprioli R.M. Proteomics in diagnostic pathology - profiling and imaging proteins directly in tissue sections. Am J Pathol 2004, 165:1057-1068.
78. Andersson M., Groseclose M.R., Deutch A.Y., Caprioli R.M. Imaging mass spectrometry of proteins and peptides: 3D volume reconstruction. Nat Meth 2008, 5:101-108.
79. Crecelius A.C., Williams B., Cornett D.S., Li X., Dawant B.M., Bodenheimer R.E., et al. 52nd ASMS Conference, Nashville, TN 2004.
80. Acquadro E., Cabella C., Ghiani S., Miragoli L., Bucci E.M., Corpillo D. Matrix-assisted laser desorption ionization imaging mass spectrometry detection of a magnetic resonance imaging contrast agent in mouse liver. Anal Chem 2009, 81:2779-2784.
81. Iverson A.A., Gillett C., Cane P., Santini C.D., Vess T.M., Kam-Morgan L., et al. A single-tube quantitative assay for mRNA levels of hormonal and growth factor receptors in breast cancer specimens. J Mol Diagn 2009, 11:117-130.
82. Rauser S., Marquardt C., Balluff B., Deininger S.-O., Albers C., Belau E., et al. Classification of HER2 receptor status in breast cancer tissues by MALDI imaging mass spectrometry. J Proteom Res 2010, 9:1854-1863.
83. Seuma J., Bunch J., Cox A., McLeod C., Bell J., Murray C. Combination of immunohistochemistry and laser ablation ICP mass spectrometry for imaging of cancer biomarkers. Proteomics 2008, 8:3775-3784.
84. Callesen A.K., Vach W., Jørgensen P.E., Cold S., Mogensen O., Kruse T.A., et al. Reproducibility of mass spectrometry based protein profiles for diagnosis of breast cancer across clinical studies: a systematic review. J Proteom Res 2008, 7:1395-1402.
85. Yanagisawa K., Shyr Y., Xu B.J., Massion P.P., Larsen P.H., White B.C., et al. Proteomic patterns of tumour subsets in non-small-cell lung cancer. Lancet 2003, 362:433-439.
86. Lemaire R., Menguellet S.A., Stauber J., Marchaudon V., Lucot J.P., Collinet P., et al. Specific MALDI imaging and profiling for biomarker hunting and validation: fragment of the 11S proteasome activator complex, Reg alpha fragment, is a new potential ovary cancer biomarker. J Proteome Res 2007, 6:4127-4134.
87. Franck J., Arafah K., Elayed M., Bonnel D., Vergara D., Jacquet A., et al. MALDI imaging mass spectrometry: state of the art technology in clinical proteomics. Mol Cell Proteomics 2009, 8:2023-2033.
88. Kang S., Shim H.S., Lee J.S., Kim D.S., Kim H.Y., Hong S.H., et al. Molecular proteomics imaging of tumor interfaces by mass spectrometry. J Proteom Res 2010, 9:1157-1164.
89. Oppenheimer SR, Mi D, Sanders ME, Caprioli RM. Molecular analysis of tumor margins by MALDI mass spectrometry in renal carcinoma. J Proteom Res 2010;9:2182-90.
90. Shimma S., Sugiura Y., Hayasaka T., Hoshikawa Y., Noda T., Setou M. MALDI-based imaging mass spectrometry revealed abnormal distribution of phospholipids in colon cancer liver metastasis. J Chromatogr B 2007, 855:98-103.
91. Walch A., Rauser S., Deininger S-O, Höfler H. MALDI imaging mass spectrometry for direct tissue analysis: a new frontier for molecular histology. Histochem Cell Biol 2008, 130:421-434.
92. Scholz B, Sköld K, Kultima K, Fernandez C, Waldemarson S, Savitski M, et al. Impact of temperature dependent sampling procedures in proteomics and peptidomics - a characterization of the liver and pancreas post mortem degradome. Mol Cell Proteomics in press. doi:10.1074/mcp.M900229-MCP200.
93. Lemaire R., Stauber J., Wisztorski M., Van Camp C., Desmons A., Deschamps M., et al. Tag-mass: specific molecular imaging of transcriptome and proteome by mass spectrometry based on photocleavable tag. J Proteome Res 2007, 6:2057-2067.
94. Thiery G., Shchepinov M.S., Southern E.M., Audebourg A., Audard V., Terris B., et al. Multiplex target protein imaging in tissue sections by mass spectrometry-TAMSIM. Rapid Commun Mass Spectrom 2007, 21:823-829.
95. McDonnell L.A., Remoortere A.V., Zeijl R.V., Dalebout H., Bladergroen M.R., André M.D. Automated imaging MS: toward high throughput imaging mass spectrometry. J Proteomics 2010, 73:1279-1282.
96. Benabdellah F., Touboul D., Brunelle A., Laprévote O. In situ primary metabolites localization on a rat brain section by chemical mass spectrometry imaging. Anal Chem 2009, 81:5557-5560.
97. Kiessling F., Le-Huu M., Kunert T., Thorn M., Vosseler S., Schmidt K., et al. Improved correlation of histological data with DCE MRI parameter maps by 3D reconstruction, reslicing and parameterization of the histological images. Eur Radiol 2005, 15:1079-1086.
98. Anderson L., Hunter C.L. Quantitative mass spectrometric MRM assays for major plasma proteins. Mol Cell Proteomics 2006, 5:573-588.
99. Picotti P., Bodenmiller B., Mueller L.N., Domon B., Aebersold R. Full dynamic range proteome analysis of S. cerevisiae by targeted proteomics. Cell 2009, 138:795-806.
100. Gerber S.A., Rush J., Stemman O., Kirschner M.W., Gygi S.P. Absolute quantification of proteins and phosphoproteins from cell lysates by tandem MS. Proc Natl Acad Sci U S A 2003, 100:6940-6945.
101. Coleman M.P., Quaresma M., Berrino F., Lutz J.M., De Angelis R., Capocaccia R., et al. Cancer survival in five continents: a worldwide population-based study (CONCORD). Lancet Oncol 2008, 9:730-756.
102. Ludwig J.A., Weinstein J.N. Biomarkers in cancer staging, prognosis and treatment selection. Nat Rev Cancer 2005, 5:845-856.
103. Mitelman F., Johansson B., Mertens F. The impact of translocations and gene fusions on cancer causation. Nat Rev Cancer 2007, 7:233-245.
104. Rennstam K., Hedenfalk I. Molecular signatures of progression from benign epithelium to metastatic breast cancer. Breast Cancer Res 2006, 8.
105. de la Chapelle A. Genetic predisposition to colorectal cancer. Nat Rev Cancer 2004, 4:769-780.
106. Geiger T.R., Peeper D.S. Metastasis mechanisms. BBA-Rev Cancer 2009, 1796:293-308.